CN106483211B - The method for measuring the content of NORMAX catalyst and its ligand - Google Patents

The method for measuring the content of NORMAX catalyst and its ligand Download PDF

Info

Publication number
CN106483211B
CN106483211B CN201610839495.6A CN201610839495A CN106483211B CN 106483211 B CN106483211 B CN 106483211B CN 201610839495 A CN201610839495 A CN 201610839495A CN 106483211 B CN106483211 B CN 106483211B
Authority
CN
China
Prior art keywords
normax
ligand
sample
dilution
rrf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610839495.6A
Other languages
Chinese (zh)
Other versions
CN106483211A (en
Inventor
刘文星
张维斌
王春江
赵安帮
徐向文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guoneng Baotou Coal Chemical Co ltd
China Shenhua Coal to Liquid Chemical Co Ltd
China Shenhua Energy Co Ltd
Original Assignee
China Shenhua Coal to Liquid Chemical Co Ltd
China Shenhua Energy Co Ltd
Shenhua Baotou Coal Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Shenhua Coal to Liquid Chemical Co Ltd, China Shenhua Energy Co Ltd, Shenhua Baotou Coal Chemical Industry Co Ltd filed Critical China Shenhua Coal to Liquid Chemical Co Ltd
Priority to CN201610839495.6A priority Critical patent/CN106483211B/en
Publication of CN106483211A publication Critical patent/CN106483211A/en
Application granted granted Critical
Publication of CN106483211B publication Critical patent/CN106483211B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/10Devices for withdrawing samples in the liquid or fluent state
    • G01N1/14Suction devices, e.g. pumps; Ejector devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/10Devices for withdrawing samples in the liquid or fluent state
    • G01N1/14Suction devices, e.g. pumps; Ejector devices
    • G01N2001/1445Overpressure, pressurisation at sampling point
    • G01N2001/1463Injector; Air-lift

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Hydrology & Water Resources (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The present invention provides a kind of methods of the content of measurement NORMAX catalyst and its ligand.This method includes preparation, correction course and the sample detection analysis of sample solution.It is detected using content of the liquid chromatogram to NORMAX catalyst and its ligand, while more appropriate liquid phase chromatogram condition is obtained by inventor's creative labor, the result measured under above-mentioned specific liquid phase chromatogram condition is more accurate.This is conducive to the content for measuring NORMAX catalyst and its ligand in time in process of production, and timely adjusting process according to testing result, to be conducive to save production cost.

Description

The method for measuring the content of NORMAX catalyst and its ligand
Technical field
The present invention relates to 2- propyl enanthol production fields, in particular to a kind of measurement NORMAX catalyst and its match The method of the content of body.
Background technique
The relatively inexpensive mixed butene of MTO device by-product, after the MTBE/ butene-1 device by pretreatment of raw material, 1- The total content of butylene and 2- butylene is about 90wt%, this provides abundant and cheap raw material for production 2- propyl enanthol product. It needs during 2- propyl enanthol carbongl group synthesis reaction using rhodium/NORMAX catalyst.The catalyst uses bulky ligand Body, so that the reaction speed of alkene and the selectivity of positive structure product greatly improve.Above-mentioned reaction is stirred in three concatenated bands It is carried out in Liquid-phase reactor, and the amount of NORMAX catalyst has vital effect to carbongl group synthesis reaction, therefore in time Accurately the content of analysis NORMAX catalyst becomes the most important thing.Furthermore NORMAX catalyst can react production with aldehyde Toxic phosphite, the phosphite in conjunction with rhodium catalyst and can cause its activity to reduce, while above-mentioned phosphite It can be reacted with water and generate strong acid aldehydic acid (HPBA), therefore analyze NORMAX catalyst and NORMAX catalyst in time in production The content of ligand is particularly important to state of arts is judged, and provides strong support to save production cost.
Summary of the invention
The main purpose of the present invention is to provide a kind of methods of the content of measurement NORMAX catalyst and its ligand, with solution Certainly carried out using content of the existing method to NORMAX catalyst and its ligand in 2- propyl enanthol carbonylation reactor solution The problem of result inaccuracy when detection.
To achieve the goals above, the present invention provides a kind of sides of the content of measurement NORMAX catalyst and its ligand Method, method include: the preparation of sample solution: using the tetraethyleneglycol dimethyl ether that has deaerated as solvent, by diphenylcyclohexyl phosphine With the tetraethyleneglycol dimethyl ether mixed preparing dilution to have deaerated;By dilution and the sample containing NORMAX catalyst and its ligand Product are mixed, and sample solution is obtained;Correction course includes: S1, using dilution as solvent, by dilution and 3,3', and 5,5'- tetra- The mixing of tert-butyl -2,2'- '-biphenyl diphenol standard sample is configured to calibration solution, concentration CSTD;S2 carries out the to calibration solution One liquid-phase chromatographic analysis is measured in parallel M times, calculates wherein the 2~M times 3,3', 5,5'- tetra-tert -2,2'- biphenyl measured The average value A of the peak area of diphenol standard sampleSTD, wherein M >=3;S3 calculates 3,3', 5,5'- tetra-terts-according to formula I The correction factor RF of 2,2'- '-biphenyl diphenol standard samples, formula I are as follows: RF=CSTD/ASTD;S4 calculates component in sample solution Relative correction factor: RRF (NORMAX)=RF × 0.660;RRF (monophosphate NORMAX ligand)=RF × 0.525;RRF (two Phosphoric acid NORMAX ligand)=RF × 0.540;RRF (rhodium NORMAX ligand)=RF × 0.853;Sample detection analysis: to sample Product solution carries out second liquid phase chromatography, obtains the peak area of each component in sample solution;According to the peak area meter of each component The concentration of NORMAX catalyst and its ligand is calculated, wherein ligand includes monophosphate NORMAX ligand, diphosphonic acid NORMAX coordination One of body and rhodium NORMAX ligand are a variety of;First liquid-phase chromatographic analysis and the condition of second liquid phase chromatography are to make With ODS-SP chromatographic column, using the mixture of methanol and/or water as mobile phase, flow velocity is 0.5~1.0mL/min, is 40 in column temperature Under conditions of DEG C, detected at wavelength 254nm using diode array detector.
Further, the collection process of sample solution includes: that nitrogen pipeline needle is passed through sample in sample detection analytical procedure In product bottle, nitrogen valve is opened, ventilate at least 5min, displaces the air in sample bottle with bilateral needle, and wherein sample bottle uses silicon Rubber plug sealing;Go out the air in syringe using nitrogen or inert gas replacement, takes 2mL nitrogen with syringe;2mL nitrogen will be sucked The syringe of gas immerses in dilution, releases the nitrogen in syringe, and draw 2mL dilution;By the dilution in syringe It is transferred to the quality W that dilution is weighed in the sample bottle filled with nitrogen1;Sample is acquired into sample bottle using bilateral needle, it is double In the first end insertion sample of cleansing pin, second end is inserted into sample bottle, and the quality W of sample is weighed2, and dilution factor calculated DF= (W1+W2)/W2
Further, the step of sample detection is analyzed includes: that sample solution is carried out second liquid phase chromatography, and parallel N times are measured, the average peak area A of each component in the calculated by peak area sample solution obtained with wherein 2~n times, wherein N >=3; The mass percentage of each component are as follows: Wt% (NORMAX)=A (NORMAX) × RRF (NORMAX) × DF;Wt% (monophosphate NORMAX ligand)=A (monophosphate NORMAX ligand) × RRF (monophosphate NORMAX ligand) × DF;Wt% (diphosphonic acid NORMAX ligand)=A (diphosphonic acid NORMAX ligand) × RRF (diphosphonic acid NORMAX ligand) × DF;Wt% (rhodium NORMAX ligand)=A (rhodium NORMAX ligand) × RRF (rhodium NORMAX ligand) × DF.
Further, the tetraethyleneglycol dimethyl ether to have deaerated is obtained by removing oxygen under nitrogen or inert atmosphere.
Further, the weight percentage of diphenylcyclohexyl phosphine is 0.1000~0.3000wt% in dilution.
Further, before the step of carrying out sample detection analysis, sample solution is filtered.
It applies the technical scheme of the present invention, is examined using content of the liquid chromatogram to NORMAX catalyst and its ligand It surveys, while more appropriate liquid phase chromatogram condition is obtained by inventor's creative labor, in above-mentioned specific liquid chromatogram Under the conditions of the result that measures it is more accurate.This is conducive to measure containing for NORMAX catalyst and its ligand in time in process of production Amount, and timely adjusting process according to testing result, to be conducive to save production cost.
Detailed description of the invention
Fig. 1 shows the content in embodiment 1 using elution requirement measurement NORMAX catalyst and its ligand in table 1 Chromatography map;And
Fig. 2 shows the contents of the elution requirement measurement NORMAX catalyst and its ligand that are used in table 2 in embodiment 1 Chromatography map.
Specific embodiment
It should be noted that in the absence of conflict, the features in the embodiments and the embodiments of the present application can phase Mutually combination.Below with reference to embodiment, the present invention will be described in detail.
As described in background technique, using existing method in 2- propyl enanthol carbonylation reactor solution Result inaccuracy when the content of NORMAX catalyst and its ligand is detected.In order to solve the above-mentioned technical problem, the present invention mentions A kind of method for having supplied content for measuring NORMAX catalyst and its ligand, this method comprises: the preparation of sample solution: to have taken off The tetraethyleneglycol dimethyl ether of gas is dilute by diphenylcyclohexyl phosphine and the tetraethyleneglycol dimethyl ether mixed preparing that has deaerated as solvent Release liquid;Dilution is mixed with the sample containing NORMAX catalyst and its ligand, obtains sample solution;Correction course packet It includes: S1, using the dilution as solvent, by the dilution and 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standard samples Product mixing is configured to calibration solution, concentration CSTD;S2 carries out the first liquid-phase chromatographic analysis to the calibration solution, parallel to survey Determine M times, calculates the peak area of wherein the 2~M times 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standard sample measured Average value ASTD, wherein M >=3;S3 calculates 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standard samples according to formula I Correction factor RF, the formula I are as follows: RF=CSTD/ASTD;S4 calculates the relative correction of other components in the calibration solution The factor: RRF (NORMAX)=RF × 0.660;RRF (monophosphate NORMAX ligand)=RF × 0.525;RRF (diphosphonic acid NORMAX ligand)=RF × 0.540;RRF (rhodium NORMAX ligand)=RF × 0.853;Sample detection analysis: molten to sample Liquid carries out second liquid phase chromatography, obtains the peak area of each component in sample solution;According to the calculated by peak area of each component The concentration of NORMAX catalyst and its ligand, wherein ligand includes monophosphate NORMAX ligand, diphosphonic acid NORMAX ligand With one of rhodium NORMAX ligand or a variety of;First liquid-phase chromatographic analysis and the condition of second liquid phase chromatography are to use ODS-SP chromatographic column, using the mixture of first alcohol and water as mobile phase, flow velocity is 0.5~1.0mL/min, the item for being 40 DEG C in column temperature Under part, detected at wavelength 254nm using diode array detector.
It is detected using content of the liquid chromatogram to NORMAX catalyst and its ligand, while being created by inventor The labour of property obtains more appropriate liquid phase chromatogram condition, and the result measured under above-mentioned specific liquid phase chromatogram condition is more quasi- Really.Furthermore the influence that process advantageously reduces systematic error to testing result is corrected before sample detection analytical procedure, To be conducive to further increase the accuracy of testing result.In conclusion being conducive to using measuring method provided by the present application The content of NORMAX catalyst and its ligand is timely and accurately measured in process of production, and adjustment in time according to testing result Technique, to be conducive to save production cost.
Preferably, elution process is pressed such as 1 institute of table during the first liquid-phase chromatographic analysis process and second liquid phase chromatography The process shown carries out.
Table 1
During said determination, the acquisition of sample can be acquired using acquisition method commonly used in the art.In one kind In preferred embodiment, the collection process of sample solution includes: that nitrogen pipeline needle is passed through sample in sample detection analytical procedure In product bottle, nitrogen valve is opened, ventilate at least 5min, displaces the air in sample bottle with bilateral needle, and wherein sample bottle uses silicon Rubber plug sealing;Go out the air in syringe using nitrogen or inert gas replacement, takes 2mL nitrogen with syringe;2mL nitrogen will be sucked The syringe of gas immerses in dilution, releases the nitrogen in syringe, and draw 2mL dilution;By the dilution in syringe It is transferred to the quality W that dilution is weighed in the sample bottle filled with nitrogen1;Sample is acquired into sample bottle using bilateral needle, it is double In the first end insertion sample of cleansing pin, second end is inserted into sample bottle, and the quality W of sample is weighed2, and dilution factor calculated DF= (W1+W2)/W2.Influence of the gases such as air to example weight in sample bottle can be removed using above-mentioned acquisition method, thus favorably In the accuracy for improving sample weighing.
In a preferred embodiment, the step of sample detection is analyzed includes: that sample solution is carried out second liquid phase Chromatography, and n times are measured in parallel, the average peak of each component in the calculated by peak area sample solution obtained with wherein 2~n times Area A, wherein N >=3;The mass percentage of each component are as follows: Wt% (NORMAX)=A (NORMAX) × RRF (NORMAX) × DF;Wt% (monophosphate NORMAX ligand)=A (monophosphate NORMAX ligand) × RRF (monophosphate NORMAX ligand) × DF;Wt% (diphosphonic acid NORMAX ligand)=A (diphosphonic acid NORMAX ligand) × RRF (diphosphonic acid NORMAX ligand) × DF;Wt% (rhodium NORMAX ligand)=A (rhodium NORMAX ligand) × RRF (rhodium NORMAX ligand) × DF.In the first liquid During analysis of hplc, it is measured in parallel n times, and the average peak area for the calculated by peak area each component for only 2~n times being taken to obtain A, this is conducive to the precision for improving testing result in detection method provided by the present application.
In a preferred embodiment, the tetraethyleneglycol dimethyl ether to have deaerated under nitrogen or inert atmosphere by removing It is obtained after oxygen.Oxygen in removing tetraethyleneglycol dimethyl ether is conducive to oxygen in suppression solution and generates to the content of measurement ingredient It influences, and influences the accuracy of subsequent detection analysis result.
In a preferred embodiment, in dilution diphenylcyclohexyl phosphine weight percentage be 0.1000~ 0.3000wt%.The concentration of diphenylcyclohexyl phosphine includes but is not limited to above range in dilution, but diphenylcyclohexyl phosphine Concentration will affect very much the separating degree of component to be measured greatly, so that will lead to chromatographic peak cannot separate.
In a preferred embodiment, before the step of carrying out sample detection analysis, sample solution was carried out Filter.This advantageously reduces influence of the impurity to testing result in sample solution, to be conducive to further improve testing result Accuracy.
Below in conjunction with specific embodiment, present invention is further described in detail, these embodiments should not be understood as limitation originally Invent range claimed.
Embodiment 1
1) preparation of dilution
Nitrogen is passed through in tetraethyleneglycol dimethyl ether and is de-gassed, the tetraethyleneglycol dimethyl ether to have been deaerated;
1.00g diphenylcyclohexyl phosphine is weighed in nitrogen glove box to be placed in the transposed 100mL vial of nitrogen, and The tetraethyleneglycol dimethyl ether to have deaerated is added into above-mentioned vial, diphenylcyclohexyl phosphine is made to be diluted to 100.00g, it is close Envelope, sufficiently shakes up and is allowed to dissolve, obtain required dilution.
2) preparation of standard solution
In nitrogen glove box, weighs 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol of 0.1197g and be placed in nitrogen and set In the 100mL vial changed, and dilute solution is added into above-mentioned vial, joins 3,3', 5,5'- tetra-terts -2,2'- Benzenediol is diluted to 100.0000g, seals and sufficiently shakes up, obtains standard solution, concentration CSTD=0.1197%.
3) correction course
According to the chromatographic condition in claim 1, standard sample is carried out parallel analysis 3 times, the sample peak after taking twice The average peak area A of area (7559923,7552506)STD=7556215, calculate 3,3', 5,5'- tetra-terts -2,2'- connection The correction factor RF=C of benzenediolSTD/ASTD=1.584 × 10-8, and then obtain the relative correction factor of all components: RRF (NORMAX)=RF × 0.660;RRF (monophosphate NORMAX ligand)=RF × 0.525;RRF (diphosphonic acid NORMAX coordination Body)=RF × 0.540;RRF (rhodium NORMAX ligand)=RF × 0.853.
4) sample detection process
Sample 1.0465g is pipetted according to claim 2, gross weight 5.5290g after dilution is added, obtains dilution gfactor DF= 5.5290/1.0465=5.2833.After filtering by the sample after mixing, it a) is analyzed according to the elution program in table 1, phase The testing result answered is shown in Fig. 1;B) it is analyzed according to the elution program in table 2, corresponding testing result is shown in Fig. 2.
Table 2
By comparing Fig. 1 and 2 it is found that rhodium NORMAX ligand non-appearance when being eluted using the elution program in table 2. It can thus be appreciated that being conducive to improve the accuracy of measurement result using the elution requirement in claim 1.
Embodiment 2
1) preparation of dilution
Nitrogen is passed through in tetraethyleneglycol dimethyl ether and is de-gassed, the tetraethyleneglycol dimethyl ether to have been deaerated;
1.00g diphenylcyclohexyl phosphine is weighed in nitrogen glove box to be placed in the transposed 100mL vial of nitrogen, and The tetraethyleneglycol dimethyl ether to have deaerated is added into above-mentioned vial, diphenylcyclohexyl phosphine is made to be diluted to 100.00g, it is close Envelope, sufficiently shakes up and is allowed to dissolve, obtain required dilution.
2) preparation of standard solution
In nitrogen glove box, 0.1197g3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol (CAS:6390- are weighed It 69-8) is put into the transposed vial of nitrogen, dilute solution is added and is diluted to 100.00g, seals and sufficiently shakes up, obtain To standard solution, concentration CSTD=0.1197%.
3) correction course
According to the chromatographic condition in claim 1, standard sample is carried out parallel analysis 3 times, the sample peak after taking twice The average value of area (7559923,7552506) obtains average peak area ASTD=7556215, calculate 3,3', 5,5'- tetra- tertiary fourths The correction factor RF=C of base -2,2'- '-biphenyl diphenolSTD/ASTD=1.584 × 10-8, and then obtain the relative correction of all components The factor: RRF (NORMAX)=RF × 0.660;RRF (monophosphate NORMAX ligand)=RF × 0.525;RRF (diphosphonic acid NORMAX ligand)=RF × 0.540;RRF (rhodium NORMAX ligand)=RF × 0.853.
4) sample detection process
C) sample 1.0465g is pipetted according to method for claim 2, gross weight 5.5290g after dilution is added, is diluted Factor D F=5.5290/1.0465=5.2833, after the sample solution filtering after mixing, according to the chromatography in claim 1 Condition carries out test sample parallel analysis 3 times, and the sample peak area after taking twice is calculated according to claim 5 The content of each component: NORMAX peak area is 1347952, concentration 745mg/kg;Monophosphate NORMAX ligand peak area is 321753, concentration 141mg/kg;Diphosphonic acid NORMAX ligand peak area is 242691, concentration 110mg/kg;Rhodium NORMAX ligand peak area is 5200089, concentration 3712mg/kg.
D) preparation sample solution is not carried out according to claim 2, sample is exposed under air conditional, first weighs sample 1.0200g is in open sample bottle, then pipettes dilution in this sample bottle, and sample and dilution gross weight are 7.1200g, shakes It is even, obtain dilution gfactor DF=7.1200/1.0200=6.9803.After the sample solution filtering after mixing, wanted according to right Seek the chromatographic condition in 1, test sample carried out parallel analysis 3 times, sample peak area after taking twice according to claim 5 into The content of each component is calculated in row: NORMAX peak area is 359154, concentration 198mg/kg;Monophosphate NORMAX ligand peak Area is 1065924, concentration 468mg/kg;Diphosphonic acid NORMAX ligand peak area is 301140, concentration 136mg/kg; Rhodium NORMAX ligand peak area is 2440044, concentration 1742mg/kg.
By analysis result it is found that if sample solution is not prepared according to the sample acquisition mode in claim 2, in sample NORMAX can occur significantly to aoxidize, and concentration is reduced to 198mg/kg, monophosphate NORMAX ligand, diphosphonic acid from 745mg/kg The content of NORMAX ligand increases, and the content of rhodium NORMAX complex reduces.It can thus be appreciated that using sample provided by the present application The acquisition mode of solution is conducive to improve the accuracy of measurement result.
Embodiment 3
1) preparation of dilution
Nitrogen is passed through in tetraethyleneglycol dimethyl ether and is de-gassed, the tetraethyleneglycol dimethyl ether to have been deaerated;
1.00g diphenylcyclohexyl phosphine is weighed in nitrogen glove box to be placed in the transposed 100mL vial of nitrogen, and The tetraethyleneglycol dimethyl ether to have deaerated is added into above-mentioned vial, diphenylcyclohexyl phosphine is made to be diluted to 100.00g, it is close Envelope, sufficiently shakes up and is allowed to dissolve, obtain required dilution.
2) preparation of standard solution
In nitrogen glove box, weighs 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol of 0.1065g and be placed in nitrogen and set In the 100mL vial changed, and dilute solution is added into above-mentioned vial, joins 3,3', 5,5'- tetra-terts -2,2'- Benzenediol is diluted to 100.00g, seals and sufficiently shakes up, obtains standard solution, concentration CSTD=0.1065wt%.
3) correction course
According to the chromatographic condition in claim 1, standard sample is carried out parallel analysis 3 times, the sample peak after taking twice The average value of area (4461345,4102705) obtains average peak area ASTD=4102705, calculate 3,3', 5,5'- tetra- tertiary fourths The correction factor RF=C of base -2,2'- '-biphenyl diphenolSTD/ASTD=2.487 × 10-8, and then obtain the relative correction of all components The factor: RRF (NORMAX)=RF × 0.660;RRF (monophosphate NORMAX ligand)=RF × 0.525;RRF (diphosphonic acid NORMAX ligand)=RF × 0.540;RRF (rhodium NORMAX ligand)=RF × 0.853.
4) sample detection process
Pipette sample 0.7400g according to method for claim 2, gross weight 4.2300g after dilution be added, obtain dilution because Sub- DF=4.2300/0.7400=5.7162, after the sample after mixing is filtered according to claim 6, according in claim 1 Chromatographic condition, by test sample carry out parallel analysis 3 times, the sample peak area after taking twice is counted according to claim 5 Calculation obtains the content of each component, and see Table 3 for details.
Table 3
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.

Claims (5)

1. a kind of method of the content of measurement NORMAX catalyst and its ligand, which is characterized in that the described method includes:
The preparation of sample solution:
Using the tetraethyleneglycol dimethyl ether that has deaerated as solvent, by diphenylcyclohexyl phosphine and the tetraethylene glycol two to have deaerated Methyl ether mixed preparing dilution;
The dilution is mixed with the sample containing the NORMAX catalyst and its ligand, it is molten to obtain the sample Liquid;
Correction course includes:
S1, using the dilution as solvent, by the dilution and 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standards Sample mixing is configured to calibration solution, concentration CSTD
S2 carries out the first liquid-phase chromatographic analysis to the calibration solution, is measured in parallel M time, what calculating wherein measured for the 2~M times The average value A of the peak area of 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standard sampleSTD, wherein M >=3;
S3 calculates the correction factor RF of 3,3', 5,5'- tetra-tert -2,2'- '-biphenyl diphenol standard samples according to formula I, described Formula I are as follows: RF=CSTD/ASTD
S4 calculates the relative correction factor of component in the sample solution:
RRF (NORMAX)=RF × 0.660;
RRF (monophosphate NORMAX ligand)=RF × 0.525;
RRF (diphosphonic acid NORMAX ligand)=RF × 0.540;
RRF (rhodium NORMAX ligand)=RF × 0.853;
Sample detection analysis:
Second liquid phase chromatography is carried out to the sample solution, obtains the peak area of each component in the sample solution;
According to the concentration of NORMAX catalyst and its ligand described in the calculated by peak area of each component, wherein the ligand includes One of monophosphate NORMAX ligand, diphosphonic acid NORMAX ligand and rhodium NORMAX ligand are a variety of;
First liquid-phase chromatographic analysis and the condition of the second liquid phase chromatography are using ODS-SP chromatographic column, with methanol And/or the mixture of water is mobile phase, flow velocity is 0.5~1.0mL/min, under conditions of column temperature is 40 DEG C, using diode Array detector is detected at wavelength 254nm;
The collection process of sample solution described in the sample detection analytical procedure includes:
Nitrogen pipeline needle is passed through in sample bottle, nitrogen valve is opened, ventilate at least 5min, displaces the sample bottle with bilateral needle In air, wherein the sample bottle is sealed using silica gel plug;
Go out the air in syringe using nitrogen or inert gas replacement, takes 2mL nitrogen with the syringe;
The syringe for sucking 2mL nitrogen is immersed in the dilution, releases the nitrogen in the syringe, and draw Dilution described in 2mL;
The dilution in the syringe is transferred in the sample bottle filled with nitrogen, the matter of the dilution is weighed Measure W1
The sample is acquired into the sample bottle using bilateral needle, the first end of the bilateral needle is inserted into the sample, Second end is inserted into the sample bottle, and the quality W of sample is weighed2, and dilution factor calculated DF=(W1+W2)/W2
2. the method according to claim 1, wherein the sample detection includes: the step of analysis
The sample solution is subjected to the second liquid phase chromatography, and is measured in parallel n times, is obtained with wherein 2~n times The average peak area A of each component in sample solution described in calculated by peak area, wherein N >=3;
The mass percentage of each component are as follows:
Wt% (NORMAX)=A (NORMAX) × RRF (NORMAX) × DF;
Wt% (monophosphate NORMAX ligand)=A (monophosphate NORMAX ligand) × RRF (monophosphate NORMAX ligand) ×DF;
Wt% (diphosphonic acid NORMAX ligand)=A (diphosphonic acid NORMAX ligand) × RRF (diphosphonic acid NORMAX ligand) ×DF;
Wt% (rhodium NORMAX ligand)=A (rhodium NORMAX ligand) × RRF (rhodium NORMAX ligand) × DF.
3. according to the method described in claim 2, it is characterized in that, the tetraethyleneglycol dimethyl ether to have deaerated by nitrogen or Oxygen is removed under inert atmosphere to obtain.
4. the method according to claim 1, wherein the weight of diphenylcyclohexyl phosphine described in the dilution Percentage composition is 0.1000~0.3000wt%.
5. according to the method described in claim 4, it is characterized in that, carry out the sample detection analysis the step of before, it is right The sample solution is filtered.
CN201610839495.6A 2016-09-21 2016-09-21 The method for measuring the content of NORMAX catalyst and its ligand Active CN106483211B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610839495.6A CN106483211B (en) 2016-09-21 2016-09-21 The method for measuring the content of NORMAX catalyst and its ligand

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610839495.6A CN106483211B (en) 2016-09-21 2016-09-21 The method for measuring the content of NORMAX catalyst and its ligand

Publications (2)

Publication Number Publication Date
CN106483211A CN106483211A (en) 2017-03-08
CN106483211B true CN106483211B (en) 2019-04-09

Family

ID=58267590

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610839495.6A Active CN106483211B (en) 2016-09-21 2016-09-21 The method for measuring the content of NORMAX catalyst and its ligand

Country Status (1)

Country Link
CN (1) CN106483211B (en)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
1-丁烯氢甲酰化反应配体的筛选与工艺条件的优化;范曼曼;《上海师范大学硕士学位论文》;20141231;1-55
刘文星.液相色谱测定戊醛中催化剂不确定度的评定.《现代测量与实验室管理》.2015,(第4期),37-39.
混合丁烯羰基合成戊醛;肖艳等;《石油化工》;20151231;第44卷(第8期);912-918

Also Published As

Publication number Publication date
CN106483211A (en) 2017-03-08

Similar Documents

Publication Publication Date Title
CN112345651B (en) Method for determining content of halogenated acid in chloral hydrate or preparation thereof
CN106053620A (en) An HS-GC/MS based method for analyzing contents of volatile organic compounds in a water-based adhesive used for cigarettes
CN104007218A (en) Determination method of bisphenol S transfer volume in plastic food packaging materials
CN112630365B (en) Method for determining content of dimyristoyl phosphatidylcholine by high performance liquid chromatography
CN102759584A (en) Method for determining pyrogallic acid through high performance liquid chromatography
CN104931634A (en) Method for detecting large-hole adsorbent resin organic matter residues in desmodium styracifolium general flavone extractive with headspace gas chromatography
CN106483211B (en) The method for measuring the content of NORMAX catalyst and its ligand
CN103091410B (en) Method for measuring phthalate type compound content in reconstituted tobacco
CN109100456B (en) Method for simultaneously determining content of 3 fat-soluble vitamins in multivitamin injection
CN115201379B (en) Method for detecting genotoxic impurities in felodipine
CN111426760B (en) Method for determining genotoxic impurities in doxofylline raw material medicine
CN112505175B (en) Method for determining content of impurities in peritoneal dialysis solution
CN110895264A (en) Method for determining ethyl bromide in tenofovir alafenamide
CN103235053A (en) Method for determining tributyl phosphate in dry food packaging paper
CN103995062B (en) Method for testing exenatide and impurities thereof by using high performance liquid chromatography
CN102331463A (en) Method for measuring content of diethylene glycol in glyceryl triacetate
CN102331470A (en) Method for determining content of bisphenol A in solution filled in feeding bottle
CN102288699B (en) Method for measuring acetic anhydride and pyridine in reaction liquid with gas phase chromatography internal standard method
CN105974017B (en) The assay method of methanol content in flavouring essence for tobacco
CN109164196A (en) A method of TMG content is measured using gas chromatography
CN114113402B (en) Method for measuring pinanediol content in bortezomib by adopting high performance liquid chromatography
CN116930368B (en) Detection method of settop alcohol isomer
CN112326860B (en) Method for simultaneously detecting genotoxic impurities of 1, 4-dichlorobutane and 1-chloro-4-hydroxybutane in bulk drug or preparation
CN114778730B (en) Method for simultaneously detecting 6 organic acids in aster medicinal material or aster product
CN102230925A (en) Method for measuring sorbic acid content in tobacco additive

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: 100011 Shenhua building, 22 West Binhe Road, Dongcheng District, Beijing

Patentee after: China Shenhua Energy Co.,Ltd.

Patentee after: Guoneng Baotou Coal Chemical Co.,Ltd.

Patentee after: CHINA SHENHUA COAL TO LIQUID AND CHEMICAL Co.,Ltd.

Address before: 100011 Shenhua building, 22 West Binhe Road, Dongcheng District, Beijing

Patentee before: China Shenhua Energy Co.,Ltd.

Patentee before: SHENHUA BAOTOU COAL CHEMICAL Co.,Ltd.

Patentee before: CHINA SHENHUA COAL TO LIQUID AND CHEMICAL Co.,Ltd.

CP01 Change in the name or title of a patent holder